Handelsbanken Fonder AB Sells 600 Shares of Teleflex Incorporated (NYSE:TFX)

Handelsbanken Fonder AB reduced its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 4.3% in the fourth quarter, Holdings Channel.com reports. The fund owned 13,300 shares of the medical technology company’s stock after selling 600 shares during the quarter. Handelsbanken Fonder AB’s holdings in Teleflex were worth $2,367,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Avior Wealth Management LLC lifted its stake in shares of Teleflex by 190.6% during the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock worth $38,000 after acquiring an additional 101 shares during the last quarter. Ashton Thomas Securities LLC bought a new stake in Teleflex during the 3rd quarter valued at $40,000. True Wealth Design LLC raised its position in Teleflex by 16,600.0% during the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock valued at $41,000 after purchasing an additional 166 shares in the last quarter. Capital Performance Advisors LLP bought a new stake in Teleflex during the 3rd quarter valued at $54,000. Finally, Banque Cantonale Vaudoise raised its position in Teleflex by 184.8% during the 3rd quarter. Banque Cantonale Vaudoise now owns 225 shares of the medical technology company’s stock valued at $56,000 after purchasing an additional 146 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on TFX shares. Mizuho decreased their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Truist Financial decreased their target price on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th. Royal Bank of Canada decreased their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $246.00.

Teleflex Trading Up 1.0 %

TFX opened at $177.45 on Tuesday. The firm has a market cap of $8.24 billion, a price-to-earnings ratio of 35.28, a PEG ratio of 1.73 and a beta of 1.16. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 12 month low of $165.62 and a 12 month high of $249.90. The stock has a fifty day moving average price of $176.98 and a 200-day moving average price of $207.11.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.